Treatment with T4 based on body weight improved hypothyroidism markers

January 2008
Endocrine Today;1/10/2008, Vol. 6 Issue 1, p41
This article discusses research being done on the use of thyroxine in the management of central hypothyroidism. It references a study by M. Slawik et al., published in a 2007 issue of the "Journal of Clinical Endocrinology and Metabolism." Twenty-nine patients with hypopituitarism were enrolled in the placebo-controlled, double blind trial. The study concluded that treatment with patients with hypopituitarism demonstrated improvement in body weight, lipid parameters and clinical signs and symptoms of hypothyroidism.


Related Articles

  • Health Status, Psychological Symptoms, Mood, and Cognition in L-Thyroxine-Treated Hypothyroid Subjects. Mary H. Samuels; Kathryn G. Schuff; Nichole E. Carlson; Phyllis Carello; Jeri S. Janowsky // Thyroid;Mar2007, Vol. 17 Issue 3, p249 

    Objective: Many hypothyroid subjects receiving L-thyroxine (L-T4) complain of psychological symptoms or cognitive dysfunction. However, there is limited validated information on these self-reports. Design: Cross-sectional comparison of 20 euthyroid and 34 treated hypothyroid subjects, aged...

  • thyroxine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p746 

    A definition of the term "thyroxine" is presented which is represented by the symbol T4, the most important thyroid hormone, and is synthesized as levothyroxine and orally administered for hypothyroidism.

  • The evaluation of transient hypothyroidism in patients diagnosed with congenital hypothyroidism. PELTEK KENDİRCİ, Havva Nur; AYCAN, Zehra; SAĞSAK, Elif; KESKİN, Melikşah; ÇETİNKAYA, Semra // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 4, p745 

    Background/aim: Congenital hypothyroidism (CH) is divided into two groups as 'permanent' and 'transient'. We aimed to determine the rate of transient and permanent congenital hypothyroidism of the newborns referred to our clinic. Materials and methods: Of the newborns who were referred to our...

  • Increasing thyroxine requirements in primary hypothyroidism: Don't forget the urinalysis! Junglee, N. A.; Scanlon, M. F.; Rees, D. A. // Journal of Postgraduate Medicine;Jul-Sep2006, Vol. 52 Issue 3, p201 

    Rising thyroid stimulating hormone (TSH) levels in patients being treated for primary hypothyroidism usually indicate poor compliance with thyroxine therapy. In rare instances, drugs or diseases affecting absorption of thyroxine or drugs that accelerate thyroxine metabolism can manifest in a...

  • A Novel In-Silico Drug Designing Approach for Identification of Natural Compounds for Treatment of Hypothyroid. Wanjari, Pankhuri; Jayadeepa, R. M. // International Proceedings of Chemical, Biological & Environmenta;2012, Vol. 31, p12 

    Hypothyroidism is an endocrine disorder characterized by abnormally low thyroid hormone production, resulting in the deficiency of thyroid hormone. Hypothyroid can be treated by giving synthetic drug intake of L-thyroxin (T4) and L-triiodothyronine (T3) as a replacement or supplementary therapy...

  • Subclinical Thyroid Disease. Wilson, George R.; Curry Jr., R. Whit // American Family Physician;10/15/2005, Vol. 72 Issue 8, p1517 

    Subclinical thyroid dysfunction is defined as an abnormal serum thyroid-stimulating hormone level (reference range: 0.45 to 4.50 µU per mL) and free thyroxine and triiodothyronine levels within their reference ranges. The management of subclinical thyroid dysfunction is controversial. The...

  • Thyroid. Sahley, Billie J. // MMRC Health Educator Reports;2007, p1 

    The article provides information related to thyroid gland. Thyroid gland is located in front of the neck and is made up of two lobes. The major hormone released by the thyroid gland directly into the bloodstream is thyroxine. In order to produce thyroid hormones, the thyroid gland needs iodine...

  • Correction: History and Future of Treatment of Hypothyroidism.  // Annals of Internal Medicine;3/1/2016, Vol. 164 Issue 5, p376 

    There is an error in a recent article. The last sentence of the section titled "L-Thyroxine Monotherapy Fails to Restore All Markers of Hypothyroidism" should read "new technology is needed to allow for steady delivery of L-triiodothyronine" (it currently reads "… for steady delivery of...

  • Consumptive hypothyroidism in an Egyptian baby with benign neonatal hemangiomatosis: a case report. Metwalley, Kotb Abbass; Farghaly, Hekma Saad // Journal of Medical Case Reports;2013, Vol. 7 Issue 1, p1 

    Introduction: Benign neonatal hemangiomatosis is a condition in which multiple cutaneous hemangiomas appear at birth or shortly thereafter; visceral complications are absent. Here, we report a case of a consumption hypothyroidism in an Egyptian baby with benign neonatal hemangiomatosis. Case...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics